- Home
- RUBI vs SXTP Comparison
RUBI vs SXTP Comparison
Compare RUBI & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RUBI | SXTP |
|---|---|---|
| Founded | N/A | 2010 |
| Country | Marshall Islands | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1M | 2.9M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | RUBI | SXTP |
|---|---|---|
| Price | $1.11 | $0.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.40 |
| AVG Volume (30 Days) | ★ 807.3K | 162.1K |
| Earning Date | 05-06-2020 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $24,139,000.00 | $1,364,945.00 |
| Revenue This Year | N/A | $146.28 |
| Revenue Next Year | N/A | $24.61 |
| P/E Ratio | $0.42 | ★ N/A |
| Revenue Growth | N/A | ★ 202.10 |
| 52 Week Low | $1.01 | $0.45 |
| 52 Week High | $200.70 | $8.00 |
Technical Indicators
Market Signals| Indicator | RUBI | SXTP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 17.44 |
| Support Level | N/A | $0.45 |
| Resistance Level | N/A | $0.73 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 10.86 |
Price Performance
Historical ComparisonAbout RUBI Rubico Inc.
Rubico Inc operates as a holding company. It is an eco-conscious international crude oil shipping company. The company's primary business is the ownership and operation of an eco-conscious fleet of tanker vessels designed for enhanced fuel efficiency, reduced greenhouse emissions, and a wide range of environmentally friendly technologies.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.